Icon

ALIQOPA - (60MG)

COPANLISIB DIHYDROCHLORIDE None
60MG
Less Than $1000 mn
None None
None None
None None
ALIQOPA is a kinase inhibitor indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies
Yes
ALIQOPA Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.